22 November 2016
Hip fracture sufferers may be able to accelerate their recovery time with the use of an established drug that is already available.
A team from Linkoping University conducted a test using teriparatide, a treatment based on the naturally-occurring parathyroid hormone that is currently used to treat osteoporosis.
Recruiting 171 patients with a pertrochanteric fracture, individuals were assigned to receive teriparatide post-surgery or another drug commonly used to treat osteoporosis, before carrying out a test of their range of movement.
Those who received teriparatide were shown to move more rapidly than those in the other group in the months following the surgery, while the pain they experienced when carrying out the test was lower. Benefits were demonstrable after six weeks and after three months.
Study leader Per Aspenberg, professor of orthopaedics at Linkoping University, said: "It's my conclusion that this study shows clearly that treatment with parathyroid hormone accelerates the healing process of fractures in such a manner that patients benefit from it."
Posted by Philip Briggs
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.